- document
-
Nybo, L. (author), Flouris, A.D. (author), Kjellstrom, T. (author), Kajfez Bogataj, L. (author), Ioannou, L.G. (author), Piil, J. (author), Morris, N.B. (author), Ciuha, U. (author), Mekjavić, I.B. (author), Bansal, A. (author), Foster, J. (author), Goodwin, J. (author), Havenith, G. (author), Crocetti, E. (author), Romeo, G. (author), Levi, M. (author), Messeri, A. (author), Morabito, M. (author), Kingma, B.R.M. (author), Pogačar, T. (author)In this report, you will find an overview of regional, industry specific and individual vulnerability to current and future occupational heat-stress. Vulnerability is considered and evaluated as productivity impact [loss] or increased heat-related health risk. The document includes regional effect analyses identifying inequalities across EU and...report 2022
- document
-
Morris, N.B. (author), Pijl, J.F. (author), Morabito, M. (author), Messeri, A. (author), Levi, M. (author), Ioannou, L.G. (author), Ciuha, U. (author), Pogacar, T. (author), Kajfez Bogataj, L. (author), Kingma, B.R.M. (author), Casanueva, A. (author), Kotlarski, S. (author), Spirig, C. (author), Foter, J. (author), Havenith, G. (author), Sotto Mayor, T. (author), Flouris, A.D. (author), Nybo, L. (author)Objectives: To provide perspectives from the HEAT-SHIELD project (www.heat-shield.eu): a multi-national, inter-sectoral, and cross-disciplinary initiative, incorporating twenty European research institutions, as well as occupational health and industrial partners, on solutions to combat negative health and productivity effects caused by working...article 2021
- document
-
Kuenen, B.C. (author), Levi, M. (author), Meijers, J.C.M. (author), Kakkar, A.K. (author), van Hinsbergh, V.W.M. (author), Kostense, P.J. (author), Pinedo, H.M. (author), Hoekman, K. (author), Gaubius Instituut TNO (author)Objective - The angiogenesis inhibitor SU5416 is a potent inhibitor of vascular endothelial growth factor (VEGF) receptor-1 and -2. VEGF may be involved in hemostasis by altering the hemostatic properties of endothelial cells. We analyzed the effects of SU5416 on the coagulation cascade and the vessel wall in patients with advanced cancer....article 2002
- document
- Menzel, D. (author), Levi, M. (author), Dooijewaard, G. (author), Peters, M. (author), ten Cate, J.W. (author), TNO Preventie en Gezondheid Instituut voor verouderings- en vaatziekten onderzoek TNO (author) article 1994
- document
- Menzel, D. (author), Levi, M. (author), Peters, M. (author), Dooijewaard, G. (author), Monnens, L. (author), ten Cate, J.W. (author), Instituut voor verouderings- en vaatziekten onderzoek TNO (author) article 1991
- document
-
Levi, M. (author), ten Cate, J.W. (author), Dooijewaard, G. (author), Sturk, A. (author), Brommer, E.J. (author), Agnelli, G. (author), Gezondheidsorganisatie TNO Gaubius instituut TNO (author)The desamino-d-arginine vasopressin (DDAVP) induced enhancement of endogenous fibrinolysis is generally attributed to the release of tissue-type plasminogen activator (t-PA) from the vessel wall. The observation of concurrent release of urokinase-type plasminogen activator (u-PA), which eventually might cooperate in the enhanced fibrinolytic...article 1989